NCT05834348 - A Study to Learn About the Effectiveness of Cancer Medicines in Patients With Metastatic Non-small Cell Lung Cancer in Norway. | Biotech Hunter

Enrollment

5,279

Participants

Timeline

Start Date

June 23, 2023

Primary Completion Date

January 23, 2024

Study Completion Date

January 23, 2024

Conditions

Non-Small Cell Lung Cancer

Interventions

DRUG

lorlatinib

As provided in real world practice

DRUG

crizotinib

As provided in real world practice

DRUG

brigatinib

As provided in real world practice

DRUG

ceritinib

As provided in real world practice

DRUG

alectinib

As provided in real world practice

DRUG

atezolizumab

As provided in real world practice

DRUG

bevacizumab

As provided in real world practice

DRUG

paclitaxel

As provided in real world practice

DRUG

carboplatin

As provided in real world practice

DRUG

docetaxel

As provided in real world practice

DRUG

erlotinib

As provided in real world practice

DRUG

gefitinib

As provided in real world practice

DRUG

afatinib

As provided in real world practice

DRUG

dacomitinib

As provided in real world practice

DRUG

osimertinib

As provided in real world practice

DRUG

pembrolizumab

As provided in real world practice

DRUG

nivolumab

As provided in real world practice

DRUG

entrectinib

As provided in real world practice

Trial Locations (1)

Unknown

Pfizer Norway, Oslo